|
ARMCX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.1555000530642E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.28869997690396E-09 |
| Normal-vs-Stage2 |
7.722500E-03 |
| Normal-vs-Stage3 |
7.082100E-03 |
| Normal-vs-Stage4 |
6.025500E-02 |
| Stage1-vs-Stage2 |
8.208000E-01 |
| Stage1-vs-Stage3 |
1.268840E-01 |
| Stage1-vs-Stage4 |
1.733710E-02 |
| Stage2-vs-Stage3 |
4.194600E-01 |
| Stage2-vs-Stage4 |
1.884650E-01 |
| Stage3-vs-Stage4 |
4.836600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.76869999996599E-07 |
| Normal-vs-AfricanAmerican |
3.782300E-02 |
| Normal-vs-Asian |
1.394910E-04 |
| Caucasian-vs-AfricanAmerican |
9.526200E-01 |
| Caucasian-vs-Asian |
1.123800E-01 |
| AfricanAmerican-vs-Asian |
2.705400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.199500E-04 |
| Normal-vs-Female |
1.18630000267572E-08 |
| Male-vs-Female |
3.616200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.81009999994575E-07 |
| Normal-vs-Age(41-60Yrs) |
2.49620000003503E-07 |
| Normal-vs-Age(61-80Yrs) |
2.319600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.899600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.893900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.486350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.486000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.686170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.098200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.93300000000441E-05 |
| Classical-VS-Follicular |
1.583630E-03 |
| Classical-VS-Other |
2.964800E-01 |
| Classical-VS-Normal |
1.10660369756488E-11 |
| Tall-VS-Follicular |
2.931600E-01 |
| Tall-VS-Other |
7.123000E-01 |
| Tall-VS-Normal |
8.402800E-01 |
| Follicular-VS-Other |
9.921400E-01 |
| Follicular-VS-Normal |
1.067830E-01 |
| Other-VS-Normal |
6.601400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.00499999953352E-07 |
| Normal-vs-N1 |
2.319400E-01 |
| N0-vs-N1 |
1.313850E-02 |
|
|
